HDL metabolism and function in diabetes mellitus.

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Lipid Metabolism

Background:

• Epidemiological studies show an inverse relationship between high-density lipoprotein (HDL) cholesterol and cardiovascular risk.
• Preclinical research indicates HDL possesses cardioprotective functions in cellular and animal models.
• Recent clinical trials of HDL-raising agents, despite failing to reduce cardiovascular events, unexpectedly improved glycemic control in type 2 diabetes patients.

Purpose of the Study:

• To review the anti-diabetic functions of HDL and apolipoprotein A1 (apoA1).
• To examine the adverse effects of diabetes mellitus on HDL structure and function.
• To explore the complex interplay between HDL and diabetes.

Main Methods:

• Review of epidemiological, preclinical, and clinical trial data.
• Analysis of studies investigating HDL and apolipoprotein A1 (apoA1) in relation to pancreatic beta-cell function and insulin sensitivity.
• Examination of how diabetes mellitus impacts HDL's structure and functions.

Main Results:

• HDL and apoA1 have demonstrated anti-diabetic properties by improving pancreatic beta-cell function and enhancing insulin sensitivity in cell and animal studies.
• Diabetes mellitus detrimentally affects the structural integrity and functional capacities, including anti-diabetic and cardioprotective roles, of HDL.

Conclusions:

• HDL exhibits significant anti-diabetic functions, contrasting with the negative impact of diabetes on HDL.
• The bidirectional relationship between HDL and diabetes warrants further investigation for potential therapeutic strategies.